Multi-Center Phase II Study With Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2016
At a glance
- Drugs Pomalidomide (Primary) ; Prednisolone
- Indications Myeloproliferative disorders
- Focus Therapeutic Use
- 18 Dec 2016 This trial was completed in Germany (end date: 2016-09-14), according to European Clinical Trials Database.
- 09 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Jul 2012 New source identified and integrated (German Clinical Trials Register; DRKS00003751).